等待開盤 06-04 09:30:00 美东时间
+0.440
+4.56%
Phathom Pharmaceuticals announced that its management team will participate in three investor conferences in May and June 2026: the Craig-Hallum Conference in Minneapolis on May 28, the Jefferies Global Healthcare Conference in New York on June 3, and the Goldman Sachs Global Healthcare Conference in Miami on June 9. The company, focused on gastrointestinal disease treatments, markets vonoprazan-based products for GERD and H. pylori infection. Mo...
05-22 12:00
Phathom Pharmaceuticals shares are trading lower. The company reported Q1 finan...
04-30 23:15
Phathom Pharmaceuticals (NASDAQ:PHAT) released first-quarter financial results ...
04-30 21:13
Companies Reporting Before The Bell • Sonic Automotive (NYSE:SAH) is projected ...
04-30 19:11
Phathom Pharmaceuticals (NASDAQ:PHAT) affirms FY2026 sales outlook from $320.000 million-$345.000 million to $320.000 million-$345.000 million vs $331.417 million estimate.
04-30 19:02
Phathom Q1 net loss narrows to $30.4 million; revenue more than doubles to $58.3 million Phathom Pharmaceuticals posted Q1 net loss of $30.4 million, narrowing from year-ago loss of $94.3 million. Revenue jumped 104% to $58.3 million. Operating loss tightened to $15.5 million from $78.9 million. VOQ
04-30 18:59
今日重点评级关注:花旗:维持Biomea Fusion"买入"评级,目标价从6美元升至7美元;Chardan Capital:维持Hyperion DeFi"买入"评级,目标价从7.75美元升至8.25美元
03-30 11:49
Top Wall Street analysts upgraded PHAT and PWR, while AGX was upgraded to Overweight with a $550 price target. Check out analysts' views on these stocks.
03-27 21:25
BUZZ-U.S. STOCKS ON THE MOVE-Alphabet, Phathom, Argan Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 March 27 (Reuters) - Wall Street's main indexes were on track to open lower
03-27 21:15